Skip to main navigation Skip to search Skip to main content

Soluble HLA-G blood levels are not increased during ongoing pregnancy in women with a history of recurrent pregnancy loss

  • J. Krop
  • , C. Van Der Keur
  • , J. M. Kapsenberg
  • , F. Den Hollander
  • , M. L.P. Van Der Hoorn
  • , S. Heidt
  • , F. H.J. Claas
  • , M. Eikmans*
  • *Corresponding author for this work
  • Leiden University
  • Leiden University Medical Centre

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)
17 Downloads (Pure)

Abstract

Recurrent pregnancy loss (RPL) affects 1–2 % of couples who are trying to conceive. At some point, some couples do maintain a healthy pregnancy to term, but the underlying mechanism of RPL remains elusive. Human leukocyte antigen (HLA)-G is an immune modulatory molecule. Our group previously showed increased HLA-G levels in the decidua of term pregnancies after RPL, while other studies showed reduced soluble HLA-G (sHLA-G) blood levels in women with RPL. This led us to investigate sHLA-G levels in blood of women with RPL who had either a subsequent pregnancy loss (RPL-pregnancy loss) or a healthy term pregnancy (RPL-live birth), and compare these to healthy control pregnancies and non-pregnant controls. Soluble HLA-G concentrations were quantified by ELISA. Women with healthy term pregnancy had increased sHLA-G levels compared to non-pregnant controls. In contrast, RPL-live birth women at term did not have increased blood sHLA-G levels. Soluble HLA-G levels remained stable between first and third trimester. Interestingly, when comparing first trimester samples of RPL-live birth to RPL-pregnancy loss, sHLA-G levels also did not significantly differ. High sHLA-G levels in blood seem not to be crucial for an ongoing healthy pregnancy after RPL. However, since it was previously shown that women with RPL-live birth have increased HLA-G levels in term decidua compared to control pregnancies, the current data suggest that local and systemic immune regulation are not necessarily in concert. Further study of the contribution of fetus-derived HLA-G and HLA-G of maternal origin may provide more insight in the pathophysiology of RPL.

Original languageEnglish
Article number103665
JournalJournal of Reproductive Immunology
Volume153
DOIs
Publication statusPublished - Sept 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022 The Authors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Soluble HLA-G blood levels are not increased during ongoing pregnancy in women with a history of recurrent pregnancy loss'. Together they form a unique fingerprint.

Cite this